Summary
- Current Price
- As of today, BRNS price is $0.59, down -11.27% on
- Current Price All-Time High
- BRNS price is currently -96.74% below its historical high of $17.99 set on
- Market Cap
- BRNS current market cap is $24M, down -44.46% year-over-year
- PE Ratio
- BRNS PE ratio is unknown
- Revenue
- BRNS current annual revenue is $14.98M, up +1760.05% year-over-year
- Next Earnings
- As of today, the next earnings release for BRNS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Barinthus Biotherapeutics plc |
| Ticker | NASDAQ: BRNS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | barinthusbio.com |
| Employees | 105 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.59 | ||
| Price, 1D Change | -11.27% | |
| $24M | ||
| - | ||
| - | ||
| 0.67 | ||
| $15M | ||
| Revenue, 1Y Change | +1,760.05% | |
| -$1.55 | ||
| EPS, 1Y Change | +19.05% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | VACC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.55 | ||
| EPS Estimate | N/A | -$1.55 |
| EPS Est. Change | N/A | +0.50% |
| $14.98M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.59 | ||
| Price Target | - | $5.50 |
| Price Tgt. Change | - | +839.21% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.96 | -$1.92 | +2.13% | |
| -$1.48 | -$1.55 | -5.15% | |
| -$1.55 | N/A | +0.50% | |
| -$1.34 | N/A | +14.03% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.25M | $805.10K | -35.59% | |
| $9.99M | $14.98M | +49.91% | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -45.27% | ||
| -81.05% | ||
| -44.46% | ||
| -79.47% | ||
| +1,760.05% | ||
| +5,487.80% | ||
| +19.05% | ||
| -13.54% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.59 | ||
| $1.02 | ||
| SMA 200 vs Price | +73.63% | |
| $0.71 | ||
| SMA 50 vs Price | +21.36% | |
| 0.67 | ||
| $0.06 | ||
| 33.33 | ||
| 92.07% | ||
| 109.04% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $14.98M | ||
| -$1.55 | ||
| $9.17M | ||
| 61.25% | ||
| -$55.43M | ||
| -370.12% | ||
| -$61.21M | ||
| -408.73% | ||
| -$49.62M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.09 | ||
| 8.03 | ||
| 8.03 | ||
| - | ||
| - | ||
| -1.81 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.28 | ||
| 0.83 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $130.03M | ||
| $110.66M | ||
| $170.14M | ||
| $125.74M | ||
| $40.01M | ||
| $15.66M | ||
| $12.01M | ||
| $1.92M | ||
| $2.47M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $76.08M | ||
| $64.60M | ||
| $5.80M | ||
| $0.00 | ||
| $5.80M | ||
| $0.00 | ||
| -$4.03M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$28.95M | ||
| -$892.40K | ||
| $2.16M | ||
| $892.40K | ||
| -$29.84M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Alliance Global Partners | → | |
| HC Wainwright & Co. | → | |
| Barclays |
Analyst sentiment
Institutional ownership
Screeners with BRNS
FAQ
What is the ticker symbol for Barinthus Biotherapeutics plc?
The ticker symbol for Barinthus Biotherapeutics plc is NASDAQ:BRNS
Does Barinthus Biotherapeutics plc pay dividends?
No, Barinthus Biotherapeutics plc does not pay dividends
What sector is Barinthus Biotherapeutics plc in?
Barinthus Biotherapeutics plc is in the Healthcare sector
What industry is Barinthus Biotherapeutics plc in?
Barinthus Biotherapeutics plc is in the Biotechnology industry
What country is Barinthus Biotherapeutics plc based in?
Barinthus Biotherapeutics plc is headquartered in United Kingdom
When did Barinthus Biotherapeutics plc go public?
Barinthus Biotherapeutics plc initial public offering (IPO) was on April 30, 2021
Is Barinthus Biotherapeutics plc in the S&P 500?
No, Barinthus Biotherapeutics plc is not included in the S&P 500 index
Is Barinthus Biotherapeutics plc in the NASDAQ 100?
No, Barinthus Biotherapeutics plc is not included in the NASDAQ 100 index
Is Barinthus Biotherapeutics plc in the Dow Jones?
No, Barinthus Biotherapeutics plc is not included in the Dow Jones index
When was Barinthus Biotherapeutics plc last earnings report?
Barinthus Biotherapeutics plc's most recent earnings report was on August 7, 2025
When does Barinthus Biotherapeutics plc report earnings?
The date for Barinthus Biotherapeutics plc's next earnings report has not been announced yet
Data Sources & References
- BRNS Official Website www.barinthusbio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1828185/000182818525000021/0001828185-25-000021-index.htm
- BRNS Profile on Yahoo Finance finance.yahoo.com/quote/BRNS
- BRNS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/brns